The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Ignatyeva V.I.
National Medical Research Centre for Therapy and Preventive Medicine
Kontsevaya A.V.
National Medical Research Center for Therapy and Preventive Medicine
Kalinina A.M.
National Medical Research Center for Therapy and Preventive Medicine
Drozdova L.Yu.
National Medical Research Center for Therapy and Preventive Medicine
Mukaneeva D.K.
National Medical Research Center for Therapy and Preventive Medicine
Drapkina O.M.
National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Socio-economic efficiency of the early cancer detection during the medical checkup
Journal: Russian Journal of Preventive Medicine. 2024;27(1): 36‑44
Views: 1113
Downloaded: 108
To cite this article:
Ignatyeva VI, Kontsevaya AV, Kalinina AM, Drozdova LYu, Mukaneeva DK, Drapkina OM. Socio-economic efficiency of the early cancer detection during the medical checkup. Russian Journal of Preventive Medicine.
2024;27(1):36‑44. (In Russ.)
https://doi.org/10.17116/profmed20242701136
Breast cancer (BC), cervical cancer (CC), and colorectal cancer (CRC) are among the most common malignant neoplasms (MN), accounting for a significant proportion of deaths due to MN in the Russian Federation. The current program of medical checkup of the adult population in the Russian Federation includes several tests aimed at early detection of these MNs.
To evaluate the socio-economic efficiency of the implementation of measures aimed at early detection of cervical, breast, and colorectal cancer as part of the medical check-up program.
The survival rate and costs of medical check-ups, as well as the subsequent life-long costs due to MN were modelled for the cohort with BC, CC and CRC identified during the medical check-ups in 2019. The same set of variables was forecasted for the situation in the absence of the medical check-up program The values of the parameters for modeling were obtained from the statistical observation data in 2019 and other published data; the costs were estimated as of 2022.
Additional costs associated with cancer screening during the medical check-ups amounted to 1.711.94 million rubles for breast cancer (3.336 life years gained), 902.74 million rubles for cervical cancer (1.734 life years gained), and 2.527.67 million rubles for the CRC (4.354 life years gained). The cost per 1 life year gained ranged from 513.2 to 1.070.6 thousand rubles, depending on the inclusion of costs due to premature death and disability. These results are below the possible limit values for this indicator (the threshold of willingness to pay) in the Russian Federation.
The results confirm the socio-economic efficiency and rationality of measures aimed at early detection of breast, cervical, and colorectal cancer included into the medical check-up program.
Keywords:
Authors:
Ignatyeva V.I.
National Medical Research Centre for Therapy and Preventive Medicine
Kontsevaya A.V.
National Medical Research Center for Therapy and Preventive Medicine
Kalinina A.M.
National Medical Research Center for Therapy and Preventive Medicine
Drozdova L.Yu.
National Medical Research Center for Therapy and Preventive Medicine
Mukaneeva D.K.
National Medical Research Center for Therapy and Preventive Medicine
Drapkina O.M.
National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Received:
18.07.2023
Accepted:
15.08.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.